Corvus Pharmaceuticals Inc (CRVS)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Richard A. Miller |
| Employees: | 30 |
| Web site: | corvuspharma.com |
|
863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, 94010
(650) 900-4520
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Corvus Pharmaceuticals, Inc. focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company was incorporated in 2014 and is based in Burlingame, California.
Please log in first to see chart